Literature DB >> 21620915

Influenza vaccine coverage, influenza-associated morbidity and all-cause mortality in Catalonia (Spain).

M Pilar Muñoz1, Núria Soldevila, Anna Martínez, Glòria Carmona, Joan Batalla, Lesly M Acosta, Angela Domínguez.   

Abstract

The objective of this work was to study the behaviour of influenza with respect to morbidity and all-cause mortality in Catalonia, and their association with influenza vaccination coverage. The study was carried out over 13 influenza seasons, from epidemiological week 40 of 1994 to week 20 of 2007, and included confirmed cases of influenza and all-cause mortality. Two generalized linear models were fitted: influenza-associated morbidity was modelled by Poisson regression and all-cause mortality by negative binomial regression. The seasonal component was modelled with the periodic function formed by the sum of the sinus and cosines. Expected influenza mortality during periods of influenza virus circulation was estimated by Poisson regression and its confidence intervals using the Bootstrap approach. Vaccination coverage was associated with a reduction in influenza-associated morbidity (p<0.001), but not with a reduction in all-cause mortality (p=0.149). In the case of influenza-associated morbidity, an increase of 5% in vaccination coverage represented a reduction of 3% in the incidence rate of influenza. There was a positive association between influenza-associated morbidity and all-cause mortality. Excess mortality attributable to influenza epidemics was estimated as 34.4 (95% CI: 28.4-40.8) weekly deaths. In conclusion, all-cause mortality is a good indicator of influenza surveillance and vaccination coverage is associated with a reduction in influenza-associated morbidity but not with all-cause mortality.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620915     DOI: 10.1016/j.vaccine.2011.04.067

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Aging Successfully: a Research and Public Health Priority for the 21(st) Century.

Authors:  Abbe N Vallejo
Journal:  Aging Dis       Date:  2012-02-29       Impact factor: 6.745

2.  Immune aging and challenges for immune protection of the graying population.

Authors:  Abbe N Vallejo
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

3.  Estimate of influenza cases using generalized linear, additive and mixed models.

Authors:  Manuel Oviedo; Ángela Domínguez; M Pilar Muñoz
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

4.  The impact of targeting all elderly persons in England and Wales for yearly influenza vaccination: excess mortality due to pneumonia or influenza and time trend study.

Authors:  Andrea G Mann; Punam Mangtani; Colin A Russell; John C Whittaker
Journal:  BMJ Open       Date:  2013-08-01       Impact factor: 2.692

5.  Molecular influenza surveillance at a tertiary university hospital during four consecutive seasons (2012-2016) in Catalonia, Spain.

Authors:  Cristina Andrés; Paula Peremiquel-Trillas; Laura Gimferrer; Maria Piñana; Maria Gema Codina; José Ángel Rodrigo-Pendás; Magda Campins-Martí; María Carmen Martín; Francisco Fuentes; Susana Rubio; Tomàs Pumarola; Andrés Antón
Journal:  Vaccine       Date:  2019-03-27       Impact factor: 3.641

6.  Geographical differences in whooping cough in Catalonia, Spain, from 1990 to 2010.

Authors:  Inma Crespo; Núria Soldevila; Pilar Muñoz; Pere Godoy; Gloria Carmona; Angela Domínguez
Journal:  BMC Public Health       Date:  2014-03-20       Impact factor: 3.295

7.  Coverage and predictors of vaccination against 2012/13 seasonal influenza in Madrid, Spain: analysis of population-based computerized immunization registries and clinical records.

Authors:  Rodrigo Jiménez-García; María D Esteban-Vasallo; Cristina Rodríguez-Rieiro; Valentín Hernandez-Barrera; M A Felicitas Domínguez-Berjón; Pilar Carrasco Garrido; Ana Lopez de Andres; Moises Cameno Heras; Domingo Iniesta Fornies; Jenaro Astray-Mochales
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.